CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Net loss	$ (5,397)	$ (19,376)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	195	52
Stock-based compensation expense	658	1,924
Bad debt expense, net of recoveries	725	(124)
Loss on disposition of assets	10	0
Noncash amortization of debt discount	136	104
Noncash interest expense associated with convertible debt	0	243
Noncash change in fair value of derivatives	(267)	10,397
Other	(7)	12
Changes in operating assets and liabilities:
Accounts receivable	(1,065)	(198)
Prepaid expenses and other current assets	(2,460)	(5,970)
Accounts payable	(401)	1,309
Accrued expenses and other current liabilities	(1,565)	(2,969)
Deferred revenue	222	591
Net cash used in operating activities	(9,216)	(14,005)
Cash flows from investing activities
Additions of property, equipment, and software	(535)	(788)
Net cash used in investing activities	(535)	(788)
Cash flows from financing activities
Proceeds from exercise of stock options	0	127
Proceeds from convertible promissory notes	0	29,374
Proceeds from business combination placed in escrow and restricted	0	39,032
Trust proceeds received from recapitalization at closing	0	582
Issuance of common Stock under ESPP	120	0
Transaction costs associated with recapitalization	0	(10,397)
Payments on related party payables	(8)	(7)
Net cash provided by financing activities	112	58,711
Net (decrease) increase in cash, cash equivalents, and restricted cash	(9,639)	43,918
Cash, cash equivalents, and restricted cash, beginning of period	25,202	28,695
Cash, cash equivalents, and restricted cash, end of period	15,563	72,613
Supplemental disclosure of non-cash financing activities
Stockholder contribution for debt issuance costs	0	924
Conversion of promissory notes into common stock	0	33,024
Issuance of forward share purchase agreements	0	14,170
Issuance of private warrants	0	3,916
Issuance of sponsor shares subject to earn-out conditions	0	6,867
Issuance of stockholder earn-out rights	$ 0	$ 26,131